论文部分内容阅读
噻甲羧肟头孢菌素(Ceftazidime)是一种新型的抗生素,它对各种革兰氏阴性杆菌包括绿脓杆菌以及吲哚阳性变形杆菌都有很强的作用。然而,它对金黄色葡萄球菌的作用却较先前的头孢菌素弱。噻甲羧肟头孢菌素不在体内代谢,大约90%从尿中排泄,肌肉或静脉注射均可。本文介绍25例败血症患者,男8例,女17例,年龄16～84岁,使用剂量为:静注1克～2克,一天2～3次;肌注每次1克,一天2～3次。
Ceftazidime is a novel antibiotic that has a potent effect on various Gram-negative bacilli, including Pseudomonas aeruginosa as well as on indole-positive Proteus. However, its effect on Staphylococcus aureus is weaker than the previous cephalosporins. Thia methylcarbophil cephalosporin metabolites are not in the body, about 90% of excretion from the urine, muscle or intravenous injection can be. This article describes 25 cases of sepsis patients, 8 males and 17 females, aged 16 to 84 years, the use of doses: intravenous 1 to 2 grams, 2 to 3 times a day; intramuscular injection of 1 gram each day, 2 to 3 Times.